Antibody Engineering & Therapeutics


Retrogenix are delighted to be attending the Antibody Engineering & Therapeutics conference from 12th – 16th December.

Our North American Business Development Manager Brad-James Gartland will be presenting at the event and will be available to discuss the Cell Microarray technology and how it can benefit your drug development pipeline.

If you are not attending the event but require further information on our technology then please do get in touch

We look forward to seeing you there!